Discriminative stimulus effects of 1-(2, 5-dimethoxy-4-methylphenyl)-2- aminopropane in rhesus monkeys: Antagonism and apparent pA2 analyses

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 3, 2009, Pages 976-981

  Li, Jun Xu ^a   Rice, Kenner C ^b   France, Charles P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIMETHOXY 4 METHYLAMPHETAMINE; 2,5 DIMETHOXY 4 N PROPYLTHIOPHENETHYLAMINE; ALPHA 1 ADRENERGIC RECEPTOR; DIPROPYLTRYPTAMINE; KETANSERIN; RITANSERIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG; VOLINANSERIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG ANTAGONISM; DRUG MECHANISM; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

EID: 62449166459     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.145458     Document Type: Article

References (27)

1. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48-58.
2. Dykstra LA (1990) Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. J Pharmacol Exp Ther 254:245-252.
3. 2 analysis. Psychopharmacol Ser 4:107-121.
4. Fantegrossi WE, Harrington AW, Eckler JR. Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, and Woods JH (2005) Hallucinogen-like actions of 2, 5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. Psychopharmacology (Berl) 181:496-503.
5. Fantegrossi WE, Murnane KS, and Reissig CJ (2008a) The behavioral pharmacology of hallucinogens. Biochem Pharmacol 75:17-33.
6. 2A receptors in rodents. Pharmacol Biochem Behav 88:358-365.
7. Fiorella D, Palumbo PA, Rabin RA, and Winter JC (1995a) The time-dependent stimulus effects of R(-)-2, 5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents. Psychopharmacology (Berl) 119:239-245.
8. 2c receptors in the stimulus effects of hallucinogenic drugs: I. Antagonist correlation analysis. Psychopharmacology (Berl) 121:347-356.
9. 2c receptors in the stimulus effects of hallucinogenic drugs: II. Reassessment of LSD false positives. Psychopharmacology (Berl) 121:357-363.
10. France CP, de Costa BR, Jacobson AE, Rice KC, and Woods JH (1990) Apparent affinity of opioid antagonists in morpMne-treated rhesus monkeys discriminating between saline and naltrexone. J Pharmacol Exp Ther 252:600-604.
11. 2 values for naltrexone studied in combination with morphine in rhesus monkeys. Psychopharmacology 193:315-321.
12. Glennon RA, Young R, and Rosecrans JA (1982) Discriminative stimulus properties of DOM and several molecular modifications. Pharmacol Biochem Behav 16:553- 556.
13. 2 antagonists. Eur J Pharmacol 91:189-196.
14. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
15. 2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277:968-981.
16. Kenakin TP (1982) The Schild regression in the process of receptor classification. Can J Physiol Pharmacol 60:249-265.
17. (2a/2c) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. J Pharmacol Exp Ther 282:747-759.
18. 1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats. Psychopharmacology (Berl) 149:377-387.
19. 2A agonist activity. Behav Pharmacol 18:283- 288.
20. Li JX, Rice KC, and France CP (2008) Discriminative stimulus effects of l-(2, 5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys. J Pharmacol Exp Ther 324:827-833.
21. Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131-181.
22. 2 values of benzodiazepine antagonists and partial agonists in monkeys. J Pharmacol Exp Ther 290:1222-1229.
23. 2A receptor antagonist MDL 100907, its enantiomer and their 3-phenolic derivatives as precursors for [HCllabeled PET ligands. Bioorg Med Chem 8:2427-2432.
24. Vickers SP, Easton N, Malcolm CS, Allen NH, Porter RH, Bickerdike MJ, and Kennett GA (2001) Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists. Pharmacol Biochem Behav 69:643- 652.
25. Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Babler A, Vogel H, and Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9:3897-3902.
26. 1A receptors. Pharmacol Biochem. Behav 65:75-82.
27. Woods JH, Bertalmio AJ, Young AM, Essman WD, and Winger G (1988) Receptor mechanisms of opioid drug discrimination. Psychopharmacol Ser 4:95-106.